Altaire Pharmaceuticals OCuSOFT Tetravisc Forte (Tetracaine HCl) 0.5% Sterile Anesthetic recall — FDA D-0443-2020
Lack of Assurance of Sterility
Complete FDA and NHTSA recall records dated in November 2019.
These records include useful source details for the selected month.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: products were not manufactured under current good manufacturing practices.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Presence of foreign substance: Brown/black particles found during stability testing.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.
Lack of Assurance of Sterility
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.